Age-Related Macular Degeneration (ARMD) Clinical Trials

Find Age-Related Macular Degeneration (ARMD) Clinical Trials Near You

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Assessment of Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aims to evaluate the progression of non-center-involving diabetic macular edema in the early postoperative period following phacoemulsification.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years.

• Both sexes.

• Patients with Grade I - Grade II nuclear cataract and non-center-involving diabetic macular edema (NCIDME).

Locations
Other Locations
Egypt
Ain Shams University
RECRUITING
Cairo
Contact Information
Primary
Hatem F Abd Elfatah, MD
tito78@yahoo.com
00201001859927
Time Frame
Start Date: 2025-06-29
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 50
Treatments
Study group
Patients with Grade I - Grade II nuclear cataract and non-center-involving diabetic macular edema (NCIDME)
Related Therapeutic Areas
Diabetic Macular Edema (DME)
Cataract Removal
Late-Onset Retinal Degeneration
Age-Related Macular Degeneration (ARMD)
Sponsors
Leads: Ain Shams University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin in Diabetic Macular Edema

Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin in Diabetic Macular Edema

Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 2/Phase 3

Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease

Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease

Enrollment Status: Recruiting
Publish Date: October 10, 2023
Intervention Type: Diagnostic test

A Phase 2, Double-masked, Randomized, Multicenter, Parallel Group, Placebo-controlled Study to Investigate the Efficacy and Safety of GAL-101, 2%, Ophthalmic Solution in Patients With Non-foveal Geographic Atrophy Secondary to Non-neovascular Age-related Macular Degeneration: eDREAM Study

A Phase 2, Double-masked, Randomized, Multicenter, Parallel Group, Placebo-controlled Study to Investigate the Efficacy and Safety of GAL-101, 2%, Ophthalmic Solution in Patients With Non-foveal Geographic Atrophy Secondary to Non-neovascular Age-related Macular Degeneration: eDREAM Study

Enrollment Status: Recruiting
Publish Date: June 25, 2025
Intervention Type: Drug
Study Phase: Phase 2
View All
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved